On day one of the Virtual ISPOR Europe 2021 conference (November 30th), researchers Harrison et al. presented work examining the differences in secondary real-world evidence (RWE) requirements between European health technology assessment (HTA) agencies. Another poster by Patel et al. used EHR to […]
Call for Abstracts: ISPOR 2022
Session and abstract submissions are now open for ISPOR 2022, the preeminent health economics and outcomes research conference. ISPOR 2022 takes place in Washington, DC, from May 15-18th. Submissions are open until December 15th, 2021 for session abstracts. Research abstracts are accepted until […]
“The Power of Patient Advocacy” – Value & Outcomes Spotlight Seeks Submissions
ISPOR’s journal Value & Outcomes Spotlight welcomes submissions for its January/February 2022 issue, which is themed, “The Power of Patient Advocacy”. The journal is requesting submissions that explore how HEOR methodologies and health policies affect patients’ healthcare decisions to […]
ISPOR Calls for Nominations for President-Elect of their 2022-2023 Board of Directors
ISPOR is seeking nominations for president-elect on the 2022-2023 ISPOR Board of Directors. In addition, there will be three vacancies for Directors opening up in the 2023-2024 term. Candidates will be reviewed by the Nominations Committee, and two nominees will be selected as President-Elect […]
ISPOR Boosts HEOR in Low & Middle-Income Countries
ISPOR pledged to promote HEOR efforts in low- to middle-income countries (LMICs) in its Strategic Plan 2024. LMICs often face difficulties attaining the financial resources for healthcare spending and are disproportionately impacted by events like the global pandemic. ISPOR has long supported HEOR […]
PhRMA President Introduces Recipients of 2020 Challenge Award, Emphasizes Commitment to Patient Centricity
The PhRMA Foundation has expanded its vision of the value assessment framework to include health equity and patient centricity. PhRMA President Eileen Cannon introduced the winning papers of the 2020 Challenge Award, intended to foster lively discussions regarding solutions to modern value […]
CEVR Director Publishes Article on Improving Data Dashboards for Drug Value Assessments
Director of the Center for the Evaluation of Value and Risk in Health (CEVR) at Tufts Medical Center Peter Neumann recently published an article in Value in Health on the impact of data dashboards on drug value assessments. Neumann calls for many improvements in how information is presented. He also […]
ISPOR 2022 Issues Call for HEOR Abstracts and Seeks Research Peer Reviewers
The International Society for Pharmacoeconomics and Outcomes (ISPOR) will host its annual conference in May 2022. ISPOR has issued a call for abstracts for issue panels, workshops, and breakout sessions. The deadline is December 15th, 2021. ISPOR is also seeking peer reviewers for submissions of […]
Value & Outcomes Spotlight Announces 2022 Themes
The 2022 themes of Value & Outcomes Spotlight are now available. They include submissions on global price transparency, patient advocacy, and COVID-19 research. “The HEOR [health economics and outcomes research] news magazine provides feature articles on timely HEOR topics, methodological and […]
Cost-Effectiveness Analyses Fail to Consider Health Equity
Although an important tool in assessing a drug’s value, cost-effectiveness analyses (CEAs) fail to account for health equity. Important information missing from CEAs includes socioeconomic status and ethnicity—critical factors when it comes to assessing outcomes. A group of healthcare stakeholders […]
